SCHEMBL20749348

SCHEMBL20749348

Cc1ccccc1CCCCOSN

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 1/20 0.48
▸ CHRM2 P08172 2/20 0.35
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ SLC16A3 O15427 1/20 0.34
▸ DAO P14920 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4A11 Q02928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18801988 0.95 TAAR1 (0.50) TAAR1CHRM2SMN1; SMN2DAOCA12
SCHEMBL4711468 0.80 TAAR1 (0.52) TAAR1CHRM2LMNAMAPTSMN1; SMN2
SCHEMBL20749271 0.79 TAAR1 (0.48) TAAR1
SCHEMBL6546757 0.79 TAAR1 (0.65) TAAR1CHRM2LMNATSHRSLC16A3
SCHEMBL16934006 0.78 TAAR1 (0.50) TAAR1CHRM2LMNAMAPTSMN1; SMN2
SCHEMBL16933760 0.78 TAAR1 (0.50) TAAR1CHRM2LMNAMAPTSMN1; SMN2
SCHEMBL8814675 0.78 TAAR1 (0.50) TAAR1CHRM2LMNAMAPTSMN1; SMN2
SCHEMBL6889270 0.78 TAAR1 (0.50) TAAR1CHRM2LMNAMAPTSMN1; SMN2
SCHEMBL18802058 0.78 TAAR1 (0.47) TAAR1CHRM2LMNASMN1; SMN2HTT
SCHEMBL8098360 0.77 TAAR1 (0.62) TAAR1CHRM2TSHRSLC16A3DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3443959-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN Bio-Pharm Solutions Co., Ltd. (KR) 2019-02-20 — — EP disclosed
Send feedback